Stockscreener 앱 받기
254.95
3.18%
7.86
시장 영업 전:
247.32
-7.63
-2.99%
Krystal Biotech Inc 주식(KRYS)의 최신 뉴스
Fed Watch: Is Krystal Biotech Inc impacted by rising rates2026 EndofMonth & Verified Swing Trading Watchlist - baoquankhu1.vn
BofA Securities Maintains Krystal Biotech(KRYS.US) With Buy Rating, Raises Target Price to $325 - Moomoo
Published on: 2026-03-23 18:50:19 - baoquankhu1.vn
Why is Krystal Biotech (KRYS) down 11.5% since last earnings report? - MSN
Krystal Biotech slips more than 2% even after Q4 earnings and revenue top estimates - MSN
KRYS SEC FilingsKrystal Biotech 10-K, 10-Q, 8-K Forms - Stock Titan
OCGN Gene Therapy Pipeline: 2026-2027 Catalysts To Watch - The Globe and Mail
Krystal Biotech Experiences Revision in Its Stock Evaluation Amid Strong Financial Performance - Markets Mojo
(KRYS) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
A Look At Krystal Biotech (KRYS) Valuation After Updated Vyjuvek Label And Pipeline Momentum - simplywall.st
Why has Krystal Biotech (KRYS) dropped 11.5% following its most recent earnings announcement? - Bitget
Why Is Krystal Biotech (KRYS) Down 11.5% Since Last Earnings Report? - Yahoo Finance
Biotech Investor Adds $3 Million to Krystal Biotech as Revenue Hits $389 Million in 2025 - AOL.com
Quarterly Trades: Is Krystal Biotech Inc impacted by rising ratesMarket Risk Report & Daily Growth Stock Investment Tips - baoquankhu1.vn
Vyjuvek Label Update And KB803 Progress Reshape Krystal Biotech Story - simplywall.st
Is It Too Late To Consider Krystal Biotech (KRYS) After Strong Multi‑Year Share Gains? - Yahoo Finance
Guidance Update: Can Krystal Biotech Inc weather a recession2026 Summary & Expert-Curated Trade Recommendations - baoquankhu1.vn
Updated YJUVEK Label and KB803 Progress Could Be A Game Changer For Krystal Biotech (KRYS) - Yahoo Finance
Whale Trades: Can Krystal Biotech Inc weather a recessionWeekly Stock Recap & Verified Chart Pattern Signals - baoquankhu1.vn
What to Know About This Obesity Drug Developer That Just Drew a New $7 Million Investment - The Motley Fool
Decheng Capital LLC Sells 33,700 Shares of Krystal Biotech, Inc. $KRYS - MarketBeat
Braidwell LP Cuts Holdings in Krystal Biotech, Inc. $KRYS - MarketBeat
Avoro Capital Advisors LLC Purchases 117,777 Shares of Krystal Biotech, Inc. $KRYS - MarketBeat
Krystal Biotech Stock Surges on Q4 Beat, But Valuation Questions Linger After CEO Share Sale - AD HOC NEWS
Assessing Krystal Biotech (KRYS) Valuation After Q4 2025 Beat And CEO Stock Sale - simplywall.st
First Trust Advisors LP Has $43.85 Million Stake in Krystal Biotech, Inc. $KRYS - MarketBeat
Capital World Investors Cuts Position in Krystal Biotech, Inc. $KRYS - MarketBeat
8,212 Shares in Krystal Biotech, Inc. $KRYS Bought by WINTON GROUP Ltd - MarketBeat
The Bull Case For Krystal Biotech (KRYS) Could Change Following Q4 Beat And CEO Stock Sales - Sahm
Krystal Biotech Insider Sold Shares Worth $6,580,270, According to a Recent SEC Filing - marketscreener.com
(KRYS) Risk Channels and Responsive Allocation - Stock Traders Daily
Krystal Biotech, Inc. $KRYS Position Trimmed by GW&K Investment Management LLC - MarketBeat
Krishnan Krish S, president of Krystal Biotech, sells $6.58 million in KRYS stock - Investing.com
Krystal Biotech (NASDAQ:KRYS) Insider Sells $6,580,250.00 in Stock - MarketBeat
Krystal Biotech director Krishnan sells $6.58 million in shares By Investing.com - Investing.com Nigeria
Krystal Biotech director Krishnan sells $6.58 million in shares - Investing.com
Krystal Biotech (KRYS) R&D president sells 25,000 shares under 10b5-1 plan - Stock Titan
[Form 4] Krystal Biotech, Inc. Insider Trading Activity - Stock Titan
KRYS Earnings History & Surprises | EPS & Revenue Results | KRYSTAL BIOTECH INC (NASDAQ:KRYS) - ChartMill
[144] Krystal Biotech, Inc. SEC Filing - Stock Titan
Segall Bryant & Hamill LLC Lowers Stock Position in Krystal Biotech, Inc. $KRYS - MarketBeat
Krystal Biotech at TD Cowen Conference: Strategic Growth and Challenges By Investing.com - Investing.com Canada
Kathryn Romano Sells 750 Shares of Krystal Biotech (NASDAQ:KRYS) Stock - MarketBeat
Daniel Janney Sells 11,803 Shares of Krystal Biotech (NASDAQ:KRYS) Stock - MarketBeat
Daniel Janney sells Krystal Biotech (KRYS) shares worth $3.25 million By Investing.com - Investing.com Canada
Daniel Janney sells Krystal Biotech (KRYS) shares worth $3.25 million - Investing.com
Krystal Biotech (KRYS) CAO sells shares and receives fresh stock awards - Stock Titan
Krystal Biotech (KRYS) R&D chief logs new awards, PSU vesting and tax trades - Stock Titan
Krystal Biotech (NASDAQ: KRYS) CEO reports new equity awards and tax share surrenders - Stock Titan
Alta Bioequities linked to Krystal Biotech (KRYS) director sells 11,803 shares - Stock Titan
Krystal Biotech, Inc. $KRYS Position Increased by William Blair Investment Management LLC - MarketBeat
TD Asset Management Boosts Stake in Krystal Biotech - National Today
TD Asset Management Inc Boosts Position in Krystal Biotech, Inc. $KRYS - MarketBeat
1.82%
자본화:
|
볼륨(24시간):